Please try another search
On Wednesday, Jones Trading adjusted its financial outlook on Rallybio Corp. (NASDAQ:RLYB), reducing the stock price target to $20 from the previous $30, while continuing to endorse the stock with a...
-- Received Protocol Assistance Feedback from European Medicines Agency on the Phase 2 Study for RLYB212; Company to Proceed Forward with Clinical Trial Application Process in Europe ---- Phase 2 Dose...
Investing.com – U.S. stocks were lower after the close on Wednesday, as losses in the Oil & Gas, Basic Materials and Technology sectors led shares lower. At the close in NYSE, the Dow Jones...
Instrument Type
Region
Sector
Industry
Date
Category
Provider